Aehr Test Systems said fiscal fourth-quarter revenue rose to $18.8 million from $14.1 million a year earlier, a gain of 33%. For the full fiscal year, revenue fell to $50.0 million from $59.0 million, a decline of 15%.
The company swung to a fiscal fourth-quarter profit of $1.4 million, or $0.04 a share, from a loss of $2.9 million, or $0.10 a share, in the same quarter last year. On a non-GAAP basis, fourth-quarter net income was $3.6 million, or $0.11 a share, versus a loss of $0.2 million, or $0.01 a share, a year ago.
Bookings hit a quarterly record of $60.7 million. Backlog stood at $80.6 million at May 29, 2026, and effective backlog, including bookings after quarter-end, reached $100.6 million. Cash, cash equivalents and restricted cash climbed to $116.5 million from $37.1 million at the end of the prior quarter.
For the full year, Aehr reported a net loss of $7.1 million, compared with a loss of $3.9 million the year before. Non-GAAP net income fell to $0.9 million from $4.6 million. Cash used in operating activities was $3.3 million.
Looking ahead, Aehr projected fiscal 2027 revenue of $130 million to $150 million, up from $50.0 million in fiscal 2026. That implies growth of roughly 160% to 200%. The company said the forecasted range is supported by its $100.6 million effective backlog and expected customer demand. Following these announcements, the company's shares moved 33.87%, and are now trading at a price of $96.40. For more information, read the company's full 8-K submission here.
